To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
322 Current news
rss
matching the following criteria
Inspecting water quality with Raman spectroscopy
24-04-2013
Scientists in the Netherlands have developed and tested a new method that uses Raman spectroscopy to identify harmful bacteria in drinking water. Water quality checks are extremely important for the health of consumers. Many of the current methods used to test water quality rely on selective ...
DNA-based asymmetric organometallic catalysis in water
27-03-2013
Scientists studying organometallic catalysts attached to DNA have used the technology to perform cyclopropanation reactions in water, and have reported efficient yields and high enantiomeric excesses. By attaching the catalytically active metal complex to a DNA scaffold, the chirality of the ...
New study on UTIs suggests flagellin is key in stimulating body's natural defenses
18-03-2013
A new study by British scientists reveals that motile Escherichia coli isolates demonstrated significant activation of NF-κB signaling suggesting that flagellin plays a key role in up-regulating the host innate defences against urinary tract infections (UTIs). UTIs are commonly caused by ...
The mysterious GRIN3A and the cause of schizophrenia
15-03-2013
Since the 1960s, psychiatrists have been hunting for substances made by the body that might accumulate in abnormally high levels to produce the symptoms associated with schizophrenia. In particular, there was a search for chemicals that might be related to the hallucinogens phencyclidine ...
Prosensa receives rare disease 'Company Award' from EURORDIS
12-03-2013
Prosensa received the ‘Company Award’ at the EURORDIS Black Pearl Gala Dinner in Brussels. The Black Pearl Gala Dinner is hosted annually by EURORDIS, a non-governmental alliance of patients and patient organizations active in the field of rare diseases, to celebrate Rare Disease Day. Awards ...
DSM and Chemtrix sign collaboration agreement in Continuous Flow Chemistry
21-02-2013
DSM Pharmaceutical Products announced that it has signed a collaboration agreement with Chemtrix B.V. in the field of Continuous Flow Chemistry to provide sustainable equipment and, development and manufacturing services to the pharmaceutical industry. The agreement brings together the ...
Optimal population size allows maximum predictability of evolution
16-01-2013
Evolution in very large populations of plants, animals or fungi can be predicted far less easily than one would expect. This has been shown by research at the Institute for Theoretical Physics of the University of Cologne and the Laboratory of Genetics at Wageningen University, part of ...
ALS TDI and to-BBB collaborate on potential treatments for Motor Neuron Disease
14-01-2013
TheALS Therapy Development Institute(ALS TDI)announcedthat it has entered into a new collaboration withto-BBBto investigate potential treatments for ALS (aka Motor Neuron or LouGehrig’sdisease). The blood-brain barrier (BBB) fortifies thewalls of blood vessels to prevent the entry of ...
PANalytical becomes distributor for OBLF product line
11-01-2013
Underlining relationship between the two companies, PANalytical and OBLF jointly announce that a formal agreement has been signed for the distribution of OBLF’s optical emission spectrometers by PANalytical in Finland, Sweden, Norway, Denmark, the Netherlands, Belgium, Luxemburg, United ...
Pepscan signs multi-target agreement for antibody discovery
10-01-2013
Pepscan Therapeutics announced a multi-target research agreement with an undisclosed US-based antibody discovery company.Under the agreement Pepscan using its CLIPS platform and other protein mimicry technologies will work with the partner in the discovery of novel antibodies. Under the ...
Netmeeting
